StocksNevro CorpNVRO

NVRO

Nevro Corp

46.15 -1.77 (-3.69%)
Delayed Prices By NASDAQ, in USD Market Open
Trade
S
46.15
B
46.45

Overview

Prev Close47.92
Day's Range 45.66 - 47.19
52 Week Range 39.30 - 121.78
Average Volume (3m)483.03K
1-Year Return-60.08%
Beta1.231
Market Cap1.7B
P/E Ratio
Revenue388.02M
EPS-3.9837
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Medical Specialties
CEO D. Keith Grossman, MBA
Employees 945

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Nevro Corp's revenues increased by 6.87% and amounted to 386.91M. Net income decreased by 58.14% to -131.36M. Net assets decreased by 21.84% to 303.62M and EPS decreased from -2.47 to -3.77.
NVRO's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
65.95%
Net Profit Margin
-21.48%
Operating Margin
-28.15%
Return On Investment
-18.18%
09/21
12/21
03/22
06/22
Total Revenue
93.21M
102.76M
87.84M
104.21M
Gross Profit
62.44M
69.13M
56.59M
70.15M
Operating Income
-26.44M
-26.22M
N/A
-23.79M
Net Income
-50.08M
-30.13M
-34.33M
-24.99M